Background illustration for clinical trials search

Paid Clinical Trials Annapolis

Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

for
Gastric Adenocarcinoma,
Location: Baltimore MD, Philadelphia PA, New Brunswick NJ,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT07001748

Phase2, Phase3, Recruiting

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

for
Multiple Myeloma, Secondary Immunodeficiency
Location: Baltimore MD, Albany NY, Detroit MI, Montreal,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06980480

Phase3, Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

for
Multiple Myeloma (MM)
Location: Baltimore MD, Brooklyn NY, New York NY, Durham NC,
Sponsor: C4 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07280013

Phase1, Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: Baltimore MD, Fairfax VA, Hershey PA, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase3, Recruiting

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

for
Plasma Cell Disorder
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT07075510

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Baltimore MD, Leesburg VA, Newark DE, Midlothian VA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Baltimore MD, Washington D.C. DC, Wilmington DE,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

for
Extensive Stage Lung Small Cell Carcinoma,
Location: Baltimore MD, Newark DE, Tappahannock VA, Richmond VA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06769126

Phase2, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: Baltimore MD, Charlottesville VA, Morristown NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase3, Recruiting

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Baltimore MD, Pittsburgh PA, Columbus OH, Cincinnati OH,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland

Sex: All

Age: 18+

Code: NCT07223814

Phase3, Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Baltimore MD, Hershey PA, Sewell NJ, Philadelphia PA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase3, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Baltimore MD, Bethesda MD, Fairfax VA, Falls Church VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase2, Recruiting

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

for
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
Location: Baltimore MD, New York NY, Morgantown WV,
Sponsor: Beat AML, LLC

Sex: All

Age: 18+

Code: NCT03013998

Phase2, Phase3, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Baltimore MD, Washington D.C. DC, Fairfax VA,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase2, Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for
Multiple Myeloma
Location: Baltimore MD, Washington D.C. DC, Newark DE,
Sponsor: European Myeloma Network B.V.

Sex: All

Age: 18+

Code: NCT05243797

Phase3, Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Baltimore MD, Richmond VA, New Brunswick NJ, Newark NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05172245

Phase1, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Baltimore MD, Washington D.C. DC, Bethesda MD,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Baltimore MD, Washington D.C. DC, Falls Church VA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase3, Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Baltimore MD, Philadelphia PA, Richmond VA, Danville PA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05633615

Phase2, Recruiting

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer (Adenocarcinoma),
Location: Baltimore MD, Boston MA, Myrtle Beach SC, Tampa FL,
Sponsor: Acerand Therapeutics (Hong Kong) Limited

Sex: Male

Age: 18+

Code: NCT06801236

Phase1, Recruiting